Patents for A61P 35 - Antineoplastic agents (221,099)
05/2013
05/01/2013EP2585454A1 Heteroaryl compounds and compositions as protein kinase inhibitors
05/01/2013EP2585115A2 Cancer therapy
05/01/2013EP2585111A1 Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
05/01/2013EP2585109A2 Compositions and methods for preventing and treating organ injury and/or dysfunction
05/01/2013EP2585107A1 Homodimeric protein constructs
05/01/2013EP2585095A1 Treatment of proliferative diseases
05/01/2013EP2585091A1 Sustained-release formulation
05/01/2013EP2585089A1 Blockade of ccl18 signaling via ccr6 as a therapeutic option in fibrotic diseases and cancer
05/01/2013EP2585082A2 One step removal of selected molecules from body fluid and tissue
05/01/2013EP2585077A1 Agent for suppressing the formation of abnormal skin cells caused by exposure to light
05/01/2013EP2585063A1 Methods of treating hematologic malignancies using 6-cyclohexyl-1-hydroxy-4-methyl-2(1h)-pyridone
05/01/2013EP2585061A2 Treatment of blood cancer
05/01/2013EP2585060A1 Stimulating immune response
05/01/2013EP2585059A1 Use of dibenzofuranone derivatives to inhibit kinases
05/01/2013EP1666481B9 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
05/01/2013CN103080334A Micro-RNA biomarkers and methods for diagnosis of early colorectal carcinoma and high-grade adenoma
05/01/2013CN103080314A Inhibitor of expression of dominantly mutated gene
05/01/2013CN103080309A Partial region polypeptide of REIC/DKK-3 protein
05/01/2013CN103080136A Anti-Axl antibodies and methods of use
05/01/2013CN103080134A Antibodies for epidermal growth factor receptor 3 (HER3)
05/01/2013CN103080131A Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies
05/01/2013CN103080125A Short and D-amino acid-containing polypeptides for therapeutic conjugates and uses thereof
05/01/2013CN103080112A Indolizine derivatives, process for the preparation thereof and therapeutic use thereof
05/01/2013CN103080111A Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof
05/01/2013CN103080109A Deuterium-enriched heterocyclic compounds as kinase inhibitors
05/01/2013CN103080107A Heteroaryl compounds and compositions as protein kinase inhibitors
05/01/2013CN103080093A Indazole compounds and their uses
05/01/2013CN103080092A Pyrazolo-quinolines
05/01/2013CN103079597A Pharmaceutical compositions comprising antisense oligonucleotides and methods of using same
05/01/2013CN103079592A Method for treating and diagnosing cancer by using cell-derived microvesicles
05/01/2013CN103079584A Method to detect endothelial cell massive calcium accumulation death
05/01/2013CN103079567A Synthetic metabolites of fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention diseases and conditions
05/01/2013CN103079551A Combination of HDAC inhibitors with thrombocytopenia drugs
05/01/2013CN103079547A Process for producing drug-block-copolymer composite and pharmaceutical product containing same
05/01/2013CN103074341A Interfering fragment and application
05/01/2013CN103074282A Tumor targeted bacterium and bactericide preparation method and metabolic product of tumor targeted bacterium
05/01/2013CN103074234A Marine fungus aspergillus sydowii and application thereof to preparation of anti-tumor medicines
05/01/2013CN103074233A Marine fungus penicillium chrysogenum and application thereof to preparation of anti-tumor medicines
05/01/2013CN103073726A Block copolymer, liquid composition, nucleic acid preparation, and preparation methods and applications thereof
05/01/2013CN103073650A Red stilbene polysaccharide 4 and effective component preparation and application
05/01/2013CN103073646A Polypeptide carrying melittin, nano-particles carrying melittin, and applications thereof
05/01/2013CN103073641A Anti-human Dlk-1 antibody showing anti-tumor activity in vivo
05/01/2013CN103073632A Potential novel cytokine LYG1 with anti-inflammatory and anti-tumor activities, and application thereof
05/01/2013CN103073620A KDR peptides and vaccines comprising the same
05/01/2013CN103073554A Substituted pyrrole chromone compound
05/01/2013CN103073553A Water-soluble naphthalocyanine base compound, preparation method and application of compound as photosensitizer
05/01/2013CN103073539A 4-(substituted phenylamino)quinazoline derivative, and preparation method, pharmaceutical composition and application thereof
05/01/2013CN103073531A 7-Difluoromethoxyl-5,4'-Dioctyl alkoxyl isoflavone synthesis method
05/01/2013CN103073529A 2-furoacridone-beta-dihydroagarofuran sesquiterpene compound in leafy parnassia, and preparation method and application thereof
05/01/2013CN103073508A Kinase inhibitor and method for treating related diseases
05/01/2013CN103073502A Synthetic method for aromatic cyclourea spiral medicine template and application of template in antineoplastic drugs
05/01/2013CN103073486A Polymorphs of N-(6-(4-chlorophenyloxy)hexyl)-N'-cyano-N"-(4-pyridyl)guanidine, and preparation methods and applications thereof
05/01/2013CN103073473A 2-p-luorobenzyl-3-hydroxy pyrrolidine amino acid, and preparation method and anticancer activity research thereof
05/01/2013CN103073451A Histone deacetylase inhibitor
05/01/2013CN103071159A Preparation method and application of adriamycin-polypeptide compound and pharmaceutical composition
05/01/2013CN103071156A Chitosan wrapped negatively-charged gold nanoparticle, and preparation method and application thereof
05/01/2013CN103071155A Graphene oxide surface-enhanced Raman scattering positioning drug carrier and preparation method thereof
05/01/2013CN103071144A Marine functional food capable of inhibiting prostatic cancer and preparation method of marine functional food
05/01/2013CN103071136A Traditional Chinese medicine health care product capable of regulating yin and yang balance of human bodies and preparation method of traditional Chinese medicine health care product
05/01/2013CN103071133A Traditional Chinese medicine composition for inhibiting cancer cell growth and traditional Chinese medicine extractant thereof
05/01/2013CN103071117A Method for extracting curcuma oil and curcumine from rhizoma curcumae longae
05/01/2013CN103071116A Traditional Chinese medicine preparation for treating esophagus cancer and preparation method thereof
05/01/2013CN103071112A Traditional Chinese medicine for curing nasopharynx cancer
05/01/2013CN103071110A Traditional Chinese medicine composition for treating colon cancer
05/01/2013CN103071106A Oral traditional Chinese medicine used for treating leukemia
05/01/2013CN103071104A Traditional Chinese medicine compound preparation for treating middle-advanced pancreatic cancer
05/01/2013CN103071100A Traditional Chinese medicine for curing lung cancer
05/01/2013CN103071099A Traditional Chinese medicine for treatment of lung cancer by pink reineckea herb
05/01/2013CN103071086A Traditional Chinese medicine preparation for treating gynecological leukorrheal diseases
05/01/2013CN103071069A Traditional Chinese medicine composition for inhibiting cancer cell growth and traditional Chinese medicine extractant thereof
05/01/2013CN103071034A Medicine for curing yin-yang deficiency type cancerous fever
05/01/2013CN103071025A Medicine for curing excessive toxic heat type cancerous fever
05/01/2013CN103071007A Medicine for treating hysteromyoma
05/01/2013CN103070983A Composition based on main components of Pu'er tea and application thereof
05/01/2013CN103070982A Traditional Chinese medicine composition for inhibiting cancer cell growth and traditional Chinese medicine extractant thereof
05/01/2013CN103070968A Traditional Chinese medicine pill for treating leukemia and preparation method of traditional Chinese medicine pill
05/01/2013CN103070912A Sophora flavescens totall flavone extract product, preparation method and quality detection method
05/01/2013CN103070905A Drug composition for curing mastocarcinoma and preparing method thereof
05/01/2013CN103070891A Capsule containing Hypericum perforatum extract
05/01/2013CN103070886A Toad skin extract dry-powder inhalant and its preparation method and use
05/01/2013CN103070885A Toad skin extract dry-powder inhalant and its preparation method and use
05/01/2013CN103070875A Composition with anticancer effect
05/01/2013CN103070874A Minodronic acid hydrate medicine composition
05/01/2013CN103070871A Pharmaceutical composition of fulvestrant
05/01/2013CN103070868A IDO inhibitor containing NH-1,2,3-triazole and preparation method thereof
05/01/2013CN103070855A Application of chrysin and acacetin in restraining telomere functions
05/01/2013CN103070837A Triptorelin Acetate slow release dripping pills
05/01/2013CN103070835A Freeze-dried composition containing bortezomib and preparation method of freeze-dried composition
05/01/2013CN103070826A Quercetin skin lipidosome, lyophilized powder thereof and preparation method and application thereof
05/01/2013CN103070825A Curcumin particle suspension used for intramuscular injection and hypodermic injection, preparation method and application
05/01/2013CN103070824A Ibandronate sodium containing injection
05/01/2013CN102676455B Preparation method for dendritic cell of umbilical cord blood source and dendritic cell vaccine
05/01/2013CN102641248B Preparation method for gemcitabine hydrochloride lyophilized preparation for injection
05/01/2013CN102552932B Method for preparing graphene oxide double-targeting medicine carrier material, and loaded medicine
05/01/2013CN102430118B Application of H22 liver cancer cell autophagosome to preparation of liver cancer therapeutic vaccine
05/01/2013CN102397275B Aromatization enzyme inhibitor
05/01/2013CN102391356B Steroid n-glycoside analogue taking dihydro-pyranoid ring as D ring and preparation and application thereof
05/01/2013CN102370979B Building method for autovaccine by aiming at human TNF(Tumor Necrosis Factor)-alpha molecule
05/01/2013CN102349934B Extraction process of effective ingredients from cordyceps mycelia
05/01/2013CN102327591B Phlegm-eliminating pill